. home.aspx

NEWS

home.aspx
   


US FDA issues CRL to Hikma’s generic version of GSK’s Advair Diskus

May 12, 2017 / pharmaceutical-technology
SHARESHARESHARE

Hikma Pharmaceuticals has received a complete response letter (CRL) from the US Food and Drug Administration (FDA) for the abbreviated new drug application (ANDA) of its.